Summary -

Key Takeaways Explained for a Non-Medical Audience

– A substantial portion of adults are undiagnosed with diabetes or pre‑diabetes when using traditional screening methods.

– Fasting glucose, OGTT, and HbA1c fail to detect many early cases of metabolic dysfunction.

– Incorporating fasting insulin and especially post‑OGTT insulin measurements markedly increases detection sensitivity.

– Postprandial insulin levels rise early in the disease process, often before glucose abnormalities become apparent.

– Elevated insulin responses after meals reflect insulin resistance and β‑cell stress.

– Early detection allows timely lifestyle or dietary interventions to prevent disease progression.

– Hyperinsulinemia, even with normal blood glucose, is a driver of cardiovascular risk.

– Relying solely on glucose‑based criteria underestimates true disease burden in populations.

– Insulin assays offer actionable biomarkers for metabolic function rather than downstream glycemic outcomes.

– Detection at the hyperinsulinemia stage may prevent irreversible β‑cell decline.

– Post‑OGTT insulin testing offers insights into dynamic metabolic responses beyond static measures.

– Early metabolic dysfunction is reversible with appropriate lifestyle changes when identified early.

– Elevated postprandial insulin is an early signal of impaired metabolic resilience.

– Broader clinical adoption of insulin assay testing could shift preventive strategies toward root‑cause metabolic restoration.